Possible activation of effector B cells during drug‐induced hypersensitivity syndrome

Possible activation of effector B cells during drug‐induced hypersensitivity syndrome

Abstract Although the development of autoimmune disorders is recognized in drug‐induced hypersensitivity syndrome (DIHS), the serial change of B‐cell activity has not been well‐addressed. Herein, the serum levels of IL‐6, IL‐10, B‐cell activating factor of the tumor necrosis factor family (BAFF), an...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yutaka Matsumura, Rei Watanabe, Yasuko Niijima, Haruka Kawakita, Junichi Furuta, Yoshiyuki Nakamura, Yosuke Ishitsuka, Naoko Okiyama, Yasuhiro Fujisawa, Manabu Fujimoto
Format: article
Langue:EN
Publié: Wiley 2021
Sujets:
APRIL
B cells
BAFF
cytokines
drug‐induced hypersensitivity syndrome
Dermatology
RL1-803
Immunologic diseases. Allergy
RC581-607
Accès en ligne:https://doaj.org/article/a195633fec104f5995783ac11eb0bd5b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/a195633fec104f5995783ac11eb0bd5b

Documents similaires